Pediatric Diabetes

NEW ORLEANS — A new study identified a link between persistent racial residential segregation and worse diabetes health in Black adolescents with type 1 diabetes.

NEW ORLEANS — Young people with type 2 diabetes taking the once-weekly GLP-1 receptor agonist dulaglutide had a decrease in HbA1c at 26 weeks without a significant change in BMI, according to findings from a phase 3 trial.

Dasiglucagon lowers the amount of IV glucose required by more than 50% for infants with congenital hyperinsulinism, according to top-line results from a phase 3 clinical trial.

A qualitative study published Diabetic Medicine highlighted the need for novel programs to improve the transition from pediatric to adult care for type 1 diabetes.

The prevalence of prediabetes more than doubled among U.S. youths from 1999 through 2018, according to findings published this week in JAMA Pediatrics.

Young adults with youth-onset type 2 diabetes developed multiple cardiovascular risk factors during a decade of follow-up, according to an analysis of follow-up data from the TODAY study.

How often do you expect to hear the statement, “The plaintiffs did not seek any monetary damages”?

More children were diagnosed with type 1 diabetes, and experienced diabetic ketoacidosis at presentation, in the first year of the COVID-19 pandemic than in the previous 5 years, according to data published in JAMA Pediatrics.

Approximately one in five girls with type 2 diabetes have polycystic ovary syndrome, according to findings of a meta-analysis in JAMA Network Open.

A supplement of Vitamin D2 may improve insulin sensitivity and slow the increase of HbA1c for children and adolescents with new-onset type 1 diabetes, according to study findings published in the Journal of the Endocrine Society.